Literature DB >> 12173405

Leishmania chagasi: uptake of iron bound to lactoferrin or transferrin requires an iron reductase.

Mary E Wilson1, Troy S Lewis, Melissa A Miller, Michael L McCormick, Bradley E Britigan.   

Abstract

Leishmania chagasi can utilize iron bound to transferrin, lactoferrin, or other chelates. We investigated the mechanism of iron uptake. Promastigotes preferentially took up iron in a reduced rather than an oxidized form, suggesting that extracellular iron must be reduced prior to internalization. Similar to literature reports, a 70-kDa protein in promastigote membrane-containing microsomes bound to [125I]-labeled transferrin. However, [125I]lactoferrin and [125I]albumin also bound a similar 70-kDa protein, suggesting that binding might not be specific. Both total and fractionated promastigotes exhibited an NADPH-dependent iron reductase activity. In contrast to trypanosomes, which take up transferrin through a specific receptor, these data support a model in which a parasite-associated or secreted reductase reduces ferric to ferrous iron, decreasing its affinity for the extracellular chelate and allowing it to be readily internalized by the parasite. This could account for the ability of the parasite to utilize iron from multiple sources in diverse host environments. Index Descriptors and Abbreviations. Index descriptors: Cryptococcus neoformans, Histoplasma capsulatum, iron, iron reductase, lactoferrin, L. chagasi, leishmaniasis, nutrient acquisition, protozoan, Saccharomyces cerevisiae, Trypanosoma brucei, Trypanosoma cruzi, transferrin; Abbreviations used: DNA, deoxyribonucleic acid; DTT, dithiothreitol; HBSS, Hanks' balanced salt solution; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; NEM, N-ethylmaleimide; RNA, ribonucleic acid.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12173405     DOI: 10.1016/s0014-4894(02)00018-8

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  22 in total

Review 1.  Nutrient transport and pathogenesis in selected parasitic protozoa.

Authors:  Scott M Landfear
Journal:  Eukaryot Cell       Date:  2011-01-07

Review 2.  Iron and Heme Metabolism at the Leishmania-Host Interface.

Authors:  Maria Fernanda Laranjeira-Silva; Iqbal Hamza; José M Pérez-Victoria
Journal:  Trends Parasitol       Date:  2020-01-28

3.  Functional characterization of LIT1, the Leishmania amazonensis ferrous iron transporter.

Authors:  Ismaele Jacques; Norma W Andrews; Chau Huynh
Journal:  Mol Biochem Parasitol       Date:  2009-12-16       Impact factor: 1.759

4.  LFR1 ferric iron reductase of Leishmania amazonensis is essential for the generation of infective parasite forms.

Authors:  Andrew R Flannery; Chau Huynh; Bidyottam Mittra; Renato A Mortara; Norma W Andrews
Journal:  J Biol Chem       Date:  2011-05-10       Impact factor: 5.157

5.  A cytochrome b561 with ferric reductase activity from the parasitic blood fluke, Schistosoma japonicum.

Authors:  Amber Glanfield; Donald P McManus; Danielle J Smyth; Erica M Lovas; Alex Loukas; Geoffrey N Gobert; Malcolm K Jones
Journal:  PLoS Negl Trop Dis       Date:  2010-11-16

Review 6.  Iron trafficking as an antimicrobial target.

Authors:  Rosanne E Frederick; Jeffery A Mayfield; Jennifer L DuBois
Journal:  Biometals       Date:  2009-04-07       Impact factor: 2.949

Review 7.  Iron acquisition within host cells and the pathogenicity of Leishmania.

Authors:  Chau Huynh; Norma W Andrews
Journal:  Cell Microbiol       Date:  2007-12-09       Impact factor: 3.715

Review 8.  Pathways of iron acquisition and utilization in Leishmania.

Authors:  Andrew R Flannery; Rebecca L Renberg; Norma W Andrews
Journal:  Curr Opin Microbiol       Date:  2013-08-17       Impact factor: 7.934

9.  Diacylglycerol-stimulated endocytosis of transferrin in trypanosomatids is dependent on tyrosine kinase activity.

Authors:  Sandesh Subramanya; Kojo Mensa-Wilmot
Journal:  PLoS One       Date:  2010-01-01       Impact factor: 3.240

Review 10.  Pumping iron: a potential target for novel therapeutics against schistosomes.

Authors:  Amber Glanfield; Donald P McManus; Greg J Anderson; Malcolm K Jones
Journal:  Trends Parasitol       Date:  2007-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.